GBLD-345 is an anxiolytic drug used in scientific research, which acts as a nonselective full agonist at GABAA receptors. It has similar effects to benzodiazepine drugs, but is structurally distinct and so is classed as a nonbenzodiazepine anxiolytic.
- ^ Davies LP, Barlin GB, Ireland SJ, Ngu MM (October 1992). "Substituted imidazo[1,2-b]pyridazines. New compounds with activity at central and peripheral benzodiazepine receptors". Biochemical Pharmacology 44 (8): 1555–61. doi:10.1016/0006-2952(92)90472-U. PMID 1358075.